Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yafen Li

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 23, 2015
Elevated preoperative neutrophil-to-lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancerJin Hong, Yan Mao, Xiaosong Chen, et al.
Plos One|August 30, 2014
Progesterone receptor status and Ki-67 index may predict early relapse in luminal B/HER2 negative breast cancer patients: a retrospective studyYu Zong, Li Zhu, Jiayi Wu, et al.
Endocrinology|July 26, 2022
CUX2/KDM5B/SOX17 Axis Affects the Occurrence and Development of Breast CancerLili Li, Genbao Zhu, Kemeng Tan, et al.
Cell Death & Disease|October 29, 2023
Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple-negative breast cancer progression and enhances the efficacy of anti-PD-1 immunotherapyRenhong Huang, Zheng Wang, Jin Hong, et al.
Epidemiology and Infection|May 21, 2020
Psychological impact of 2019 novel coronavirus (2019-nCoV) outbreak in health workers in ChinaDandan Sun, Dongliang Yang, Yafen Li, et al.
Breast Cancer Research and Treatment|December 16, 2022
Neoadjuvant docetaxel, epirubicin, and cyclophosphamide with or without metformin in breast cancer patients with metabolic abnormality: results from the randomized Phase II NeoMET trialJiahui Huang, Yiwei Tong, Jin Hong, et al.
Plos One|August 26, 2014
Presence of CHD1L over-expression is associated with aggressive tumor biology and is a novel prognostic biomarker for patient survival in human breast cancerJiayi Wu, Yu Zong, Xiaochun Fei, et al.
Oncotargets and Therapy|August 28, 2020
Biomarkers of Insulin and the Insulin-Like Growth Factor Axis in Relation to Breast Cancer Risk in Chinese WomenYifei Zhu, Tiange Wang, Jiayi Wu, et al.
Cancer Research and Treatment|February 13, 2019
Changes of Tumor Infiltrating Lymphocytes after Core Needle Biopsy and the Prognostic Implications in Early Stage Breast Cancer: A Retrospective StudyJiahui Huang, Xiaosong Chen, Xiaochun Fei, et al.
Annals of Surgical Oncology|May 31, 2019
Clinicopathological Features and Disease Outcome in Breast Cancer Patients with Hormonal Receptor Discordance between Core Needle Biopsy and Following Surgical SampleSiji Zhu, Jiayi Wu, Ou Huang, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 23, 2015
Elevated preoperative neutrophil-to-lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancerJin Hong, Yan Mao, Xiaosong Chen, et al.
Plos One|August 30, 2014
Progesterone receptor status and Ki-67 index may predict early relapse in luminal B/HER2 negative breast cancer patients: a retrospective studyYu Zong, Li Zhu, Jiayi Wu, et al.
Endocrinology|July 26, 2022
CUX2/KDM5B/SOX17 Axis Affects the Occurrence and Development of Breast CancerLili Li, Genbao Zhu, Kemeng Tan, et al.
Cell Death & Disease|October 29, 2023
Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple-negative breast cancer progression and enhances the efficacy of anti-PD-1 immunotherapyRenhong Huang, Zheng Wang, Jin Hong, et al.
Epidemiology and Infection|May 21, 2020
Psychological impact of 2019 novel coronavirus (2019-nCoV) outbreak in health workers in ChinaDandan Sun, Dongliang Yang, Yafen Li, et al.
Breast Cancer Research and Treatment|December 16, 2022
Neoadjuvant docetaxel, epirubicin, and cyclophosphamide with or without metformin in breast cancer patients with metabolic abnormality: results from the randomized Phase II NeoMET trialJiahui Huang, Yiwei Tong, Jin Hong, et al.
Plos One|August 26, 2014
Presence of CHD1L over-expression is associated with aggressive tumor biology and is a novel prognostic biomarker for patient survival in human breast cancerJiayi Wu, Yu Zong, Xiaochun Fei, et al.
Oncotargets and Therapy|August 28, 2020
Biomarkers of Insulin and the Insulin-Like Growth Factor Axis in Relation to Breast Cancer Risk in Chinese WomenYifei Zhu, Tiange Wang, Jiayi Wu, et al.
Cancer Research and Treatment|February 13, 2019
Changes of Tumor Infiltrating Lymphocytes after Core Needle Biopsy and the Prognostic Implications in Early Stage Breast Cancer: A Retrospective StudyJiahui Huang, Xiaosong Chen, Xiaochun Fei, et al.
Annals of Surgical Oncology|May 31, 2019
Clinicopathological Features and Disease Outcome in Breast Cancer Patients with Hormonal Receptor Discordance between Core Needle Biopsy and Following Surgical SampleSiji Zhu, Jiayi Wu, Ou Huang, et al.
Pageof 11